Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Romanos Sklavenitis Pistofidis, M.D.

Concepts (78)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma9202250961.150 Why?
HMGA1a Protein12021630.750 Why?
Waldenstrom Macroglobulinemia3202110660.520 Why?
Receptors, CXCR4120187300.450 Why?
RNA-Binding Proteins1202118860.400 Why?
Adaptor Proteins, Signal Transducing1202128850.360 Why?
Monoclonal Gammopathy of Undetermined Significance220201750.290 Why?
Gene Expression Regulation, Neoplastic1202183560.250 Why?
Neoplasm Recurrence, Local1202191930.210 Why?
Disease Models, Animal12021178690.200 Why?
Immunologic Factors2202215670.190 Why?
Bone Marrow3202129020.190 Why?
Clinical Trials, Phase II as Topic120226270.170 Why?
Disease Progression52022133170.170 Why?
Receptor, Interferon alpha-beta120181040.150 Why?
Plasma Cells120215890.150 Why?
Sequence Analysis, RNA2202119790.130 Why?
Mice, SCID1202126210.130 Why?
Stromal Cells1202113010.130 Why?
Mutation22019296270.120 Why?
Clone Cells1201816520.120 Why?
Cell Adhesion1202130890.120 Why?
Cell Proliferation22021103110.110 Why?
Tumor Cells, Cultured1202161420.110 Why?
Neoplasms, Experimental1201812290.110 Why?
Chromosome Aberrations1201817750.100 Why?
Tumor Microenvironment2202136950.100 Why?
Antibodies, Viral1202130740.090 Why?
Neoplasms, Second Primary1201810530.090 Why?
Immunoglobulin G1202144810.090 Why?
Base Sequence12021124560.090 Why?
Survival Rate22021126450.090 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma1201815160.080 Why?
Immune Tolerance1201822160.080 Why?
Cell Movement1202151660.080 Why?
Decision Support Techniques1201919590.080 Why?
High-Throughput Nucleotide Sequencing1202036140.070 Why?
Asymptomatic Diseases220215650.070 Why?
Immunotherapy1202245930.070 Why?
Neoplasm Proteins1201836110.070 Why?
Prognosis32021290790.060 Why?
Apoptosis1202194470.060 Why?
T-Lymphocytes, Regulatory1201830120.060 Why?
Genomics1202056950.060 Why?
Humans1220227466300.060 Why?
Follow-Up Studies32019387710.050 Why?
Immunologic Tests120211020.050 Why?
Hematopoietic Stem Cell Transplantation1201854580.040 Why?
Risk2202295220.040 Why?
Models, Immunological120215070.040 Why?
Mice32021802510.040 Why?
beta 2-Microglobulin120193150.040 Why?
Antibodies, Blocking120182310.040 Why?
Female620213824500.040 Why?
Antibodies, Neoplasm120182800.040 Why?
Immunocompromised Host120218470.030 Why?
Myeloid Differentiation Factor 88120195780.030 Why?
Animals320211665580.030 Why?
Immunoglobulin M1201915080.030 Why?
Risk Factors42022724470.030 Why?
Male520213514200.020 Why?
Transplantation, Homologous1201846220.020 Why?
Disease-Free Survival1201967890.020 Why?
Biopsy1201967340.020 Why?
Combined Modality Therapy1201885210.020 Why?
Boston1201992130.020 Why?
Aged, 80 and over22020575860.010 Why?
Phenotype12022162610.010 Why?
Cell Line12018156420.010 Why?
Mice, Knockout12018142530.010 Why?
Predictive Value of Tests12019150100.010 Why?
Aged320201643830.010 Why?
Middle Aged320202146180.010 Why?
Adult320202151920.010 Why?
Risk Assessment12019234640.010 Why?
Time Factors12019396220.010 Why?
Prospective Studies12021532530.010 Why?
Signal Transduction12018231540.010 Why?
Sklavenitis Pistofidis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (30)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.